At a Glance
| 1cP-AL-LAD | 25B-NBOMe | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | oral | sublingualinsufflated |
| Effects | 72 documented | 42 documented |
Dosage
Only in 1cP-AL-LAD
oral
| Level | Dose |
|---|---|
| Threshold | 20 µg |
| Light | 50–100 µg |
| Common | 100–225 µg |
| Strong | 225–350 µg |
| Heavy | 350 µg |
Only in 25B-NBOMe
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 100–300 µg |
| Common | 300–500 µg |
| Strong |
Duration
Only in 1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up30 min – 1 hrs
Peak2.5 hrs – 5 hrs
Offset2 hrs – 3 hrs
Effects
Safety
Interaction: 1cP-AL-LAD + 25B-NBOMe
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-AL-LAD and 25B-NBOMe?
1cP-AL-LAD is classified as a Psychedelic (Lysergamides) while 25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 34 effects in common, with 38 effects unique to 1cP-AL-LAD and 8 unique to 25B-NBOMe.
Is it safe to combine 1cP-AL-LAD and 25B-NBOMe?
There is no direct interaction data available for combining 1cP-AL-LAD and 25B-NBOMe. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-AL-LAD or 25B-NBOMe?
1cP-AL-LAD and 25B-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.